Technical Analysis for ORGS - Orgenesis Inc

Grade Last Price % Change Price Change
grade D 4.49 -5.27% -0.2500
ORGS closed down 5.27 percent on Friday, January 25, 2019, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical ORGS trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Reversal New Lows Setup Bearish Swing Setup -5.27%
Wide Bands Range Expansion -5.27%
Oversold Stochastic Weakness -5.27%
Bullish Engulfing Bullish -10.20%
Narrow Range Bar Range Contraction -10.20%
NR7 Range Contraction -10.20%
Wide Bands Range Expansion -10.20%

Older signals for ORGS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Orgenesis Inc. is a regenerative therapy company. The Company operates through two segments: Contract Development and Manufacturing Organization (CDMO) and Cellular Therapy Business (CTB). The CDMO activity is operated by the Company's subsidiary, MaSTherCell SA, which specializes in cell therapy development for advanced medicinal products. MaSTherCell is providing two types of services to its customers: process and assay development services and good manufacturing practice (GMP) contract manufacturing services. The CTB activity is based on its technology that demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and differentiating (converting) them into pancreatic beta cell-like insulin producing cells for patients with Type I Diabetes. It intends to advance a product that combines cell-based therapy and regenerative medicine, Autologous Insulin Producing (AIP) cells, into clinical development.
Biotechnology RTT Branches Of Biology Diabetes Stem Cells Regenerative Medicine Cell Therapy Endocrine System Contract Manufacturing Services Hormones Peptide Hormones Insulin Contract Development And Manufacturing Organization Diabetes Mellitus Type 1 I Diabetes Manufacturing Practice
Is ORGS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 10.75
52 Week Low 0.23
Average Volume 25,953
200-Day Moving Average 2.9423
50-Day Moving Average 7.871
20-Day Moving Average 6.9398
10-Day Moving Average 5.43
Average True Range 0.6527
ADX 30.7
+DI 15.3286
-DI 39.5798
Chandelier Exit (Long, 3 ATRs ) 7.841900000000001
Chandelier Exit (Short, 3 ATRs ) 6.4081
Upper Bollinger Band 10.2772
Lower Bollinger Band 3.6024
Percent B (%b) 0.13
BandWidth 96.181446
MACD Line -0.9017
MACD Signal Line -0.6009
MACD Histogram -0.3008
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.8875
Resistance 3 (R3) 4.9183 4.8167 4.8213
Resistance 2 (R2) 4.8167 4.7154 4.8013 4.7991
Resistance 1 (R1) 4.6533 4.6529 4.6025 4.6225 4.7771
Pivot Point 4.5517 4.5517 4.5263 4.5363 4.5517
Support 1 (S1) 4.3883 4.4504 4.3375 4.3575 4.2029
Support 2 (S2) 4.2867 4.3879 4.2713 4.1809
Support 3 (S3) 4.1233 4.2867 4.1588
Support 4 (S4) 4.0925